Tag: 21st Century Cure Act

Booz Allen, Octo Consulting Land Spots on $300M FDA Data Tech Modernization BPA

The Food and Drug Administration has awarded Booz Allen Hamilton (NYSE: BAH) and Octo Consulting Group spots on a potential